Pharmaceutical Gelatin Market - Global Forecast 2026-2032

Pharmaceutical gelatin is a cornerstone excipient connecting raw material sourcing to finished drug delivery, making it essential to both formulation performance and supply chain reliability. This overview offers decisive insights for senior leaders seeking to navigate evolving quality, compliance, and sourcing challenges in the pharmaceutical gelatin market.

Market Snapshot: Pharmaceutical Gelatin Market Overview

The Pharmaceutical Gelatin Market grew from USD 1.30 billion in 2025 to USD 1.38 billion in 2026. It is expected to continue growing at a CAGR of 6.18%, reaching USD 1.98 billion by 2032. This trajectory highlights robust demand for gelatin in diverse drug delivery applications, as manufacturers prioritize performance consistency and regulatory assurance amid supply chain shifts and new certification mandates.

Scope & Segmentation

This report comprehensively analyzes the pharmaceutical gelatin landscape, focusing on the technical, regulatory, and commercial drivers of market evolution. Segmentation offers senior decision-makers a framework for strategic planning across sourcing, application, and distribution channels:

Source: Bovine gelatin is widely adopted for its functional reliability, fish-derived gelatin is used where dietary or religious preferences require alternatives, and porcine gelatin is selected for specific gel strength requirements and bloom characteristics.
Type: Type A gelatin (acid processed) provides unique molecular profiles for targeted formulations; Type B (alkaline processed) enables alternative performance attributes.
Form: Powder formats offer processing flexibility and longer shelf life; sheet gelatin ensures dimensional accuracy for critical capsule and coating applications.
Application: Hard and soft capsules, multiparticulate systems, pellet coatings, and tablet films each depend on distinct gelatin properties, from controlled gelation to plasticizer compatibility.
Distribution Channel: Direct procurement enhances technical collaboration and control, distributor channels add geographic reach and inventory buffers, and online platforms provide speed but require rigorous compliance verification.
Region: Americas emphasize compliance and supply chain robustness, EMEA segments see strong demand for certification and traceability, and Asia-Pacific provides scale, cost efficiency, and technical specialization.
Technology: Advanced peptide profiling, chromatography, and digital traceability systems ensure alignment with evolving regulatory and formulation needs.

Key Takeaways

Pharmaceutical gelatin is recognized as a performance-critical excipient directly influencing drug release characteristics, encapsulation efficacy, and patient acceptability.
Sustainability imperatives are reshaping sourcing criteria, with traceable origin, verified processing, and certification now central to supplier qualification.
Technological advances in analytical testing and digital documentation facilitate tighter alignment between supplier output and specific formulation requirements.
Regional specialization impacts procurement strategies; buyers balance cost efficiency with certification, reliability, and documentation standards in diverse markets.
Quality assurance, technical service, and transparent traceability systems have emerged as key factors that differentiate leading gelatin suppliers and bolster customer confidence.

Tariff Impact

Tariff adjustments triggered a shift toward total landed cost evaluation by procurement leaders, emphasizing logistics, inventory, and lead-time considerations over unit price alone.
Firms have diversified supplier portfolios and invested in nearshoring or regional sourcing to mitigate cost volatility and supply disruption exposure.
Expanded collaboration between producers and pharmaceutical manufacturers facilitates rapid technical transfer and tighter regulatory compliance in the context of new tariff regimes.

Methodology & Data Sources

The report synthesizes in-depth interviews with formulation experts, supplier audits, and lab-based testing of key attributes such as bloom strength and molecular distribution. Secondary evidence from regulatory guidance, certification documentation, and pharmacopeial standards is integrated to validate market insights. Data triangulation and repeat testing support reliability and transparency of findings.

Why This Report Matters

Enables procurement and technical leaders to anticipate compliance risks, optimize sourcing strategies, and maintain product integrity within shifting regulatory and trade environments.
Equips organizations to identify certified suppliers with robust quality systems, technical capabilities, and digital traceability solutions aligned with evolving market expectations.
Supports risk management, cost optimization, and long-term supply continuity through actionable analysis of market drivers, supplier differentiation, and regional dynamics.

Conclusion

Senior leaders must address integrated technical, regulatory, and supply demands to ensure resilient pharmaceutical gelatin strategies. Strategic alignment across sourcing, quality assurance, and traceability will help organizations safeguard formulation performance and market adaptability.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Gelatin Market, by Type

8.1. Type A
8.2. Type B

9. Pharmaceutical Gelatin Market, by Form

9.1. Powder
9.2. Sheet

10. Pharmaceutical Gelatin Market, by Raw Material

10.1. Skin
10.2. Bone
10.3. Combined Skin And Bone

11. Pharmaceutical Gelatin Market, by Application

11.1. Hard Capsule
11.2. Pellets
11.3. Soft Capsule
11.4. Tablet Coating

12. Pharmaceutical Gelatin Market, by Distribution Channel

12.1. Offline
12.2. Online

13. Pharmaceutical Gelatin Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Pharmaceutical Gelatin Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Pharmaceutical Gelatin Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Pharmaceutical Gelatin Market
17. China Pharmaceutical Gelatin Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Danish Crown Protein A/S
18.6. Darling Ingredients Inc.
18.7. Gelco International
18.8. Gelita AG
18.9. Italgelatin SpA
18.10. Lonza Group AG
18.11. MV Protein Inc.
18.12. Nippi Inc.
18.13. Nitta Gelatin Inc.
18.14. Norland Products Inc.
18.15. PB Leiner NV
18.16. Tessenderlo Group NV
18.17. Weishardt International SAS

List of Figures

FIGURE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SKIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SKIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SKIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COMBINED SKIN AND BONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COMBINED SKIN AND BONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COMBINED SKIN AND BONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 73. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 74. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 75. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 85. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 86. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 87. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 98. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 99. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 100. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 104. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 105. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 106. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 116. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 117. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 118. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 122. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 123. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 124. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 128. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 129. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 130. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 141. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 142. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
TABLE 143. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Pharmaceutical Gelatin market report include:

Danish Crown Protein A/S
Darling Ingredients Inc.
Gelco International
Gelita AG
Italgelatin SpA
Lonza Group AG
MV Protein Inc.
Nippi Inc.
Nitta Gelatin Inc.
Norland Products Inc.
PB Leiner NV
Tessenderlo Group NV
Weishardt International SAS

Table Information

Report Attribute	Details
No. of Pages	197
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.38 Billion
Forecasted Market Value ( USD ) by 2032	$ 1.98 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	14

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3400EUR$3,939USD£2,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3668EUR$4,249USD£3,178GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4971EUR$5,759USD£4,307GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6016EUR$6,969USD£5,212GBP

Market Snapshot: Pharmaceutical Gelatin Market Overview

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Gelatin Market - Global Forecast 2026-2032

Food Grade Gelatin Market - Global Forecast 2026-2032

Pharmaceutical Gelatin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

Pharmaceutical Gelatin: Market Share, and Growth Analysis by Product Type (Type a, Type B, Type C), Application, End User, Technology

Bovine Gelatin Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)